Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    May 2017
  1. ZHENG G, Lu H, Yu W, Luo S, et al
    Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4809.
    PubMed     Text format     Abstract available


  2. HWANG J, Kim YK, Min JH, Choi SY, et al
    Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
    Eur Radiol. 2017 May 12. doi: 10.1007/s00330-017-4846.
    PubMed     Text format     Abstract available


  3. POOLER BD, Lubner MG, Kim DH, Chen OT, et al
    Prospective Evaluation of Reduced Dose Computed Tomography for the Detection of Low-Contrast Liver Lesions: Direct Comparison with Concurrent Standard Dose Imaging.
    Eur Radiol. 2017;27:2055-2066.
    PubMed     Text format     Abstract available


    April 2017
  4. TAOULI B, Hoshida Y, Kakite S, Chen X, et al
    Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
    Eur Radiol. 2017 Apr 24. doi: 10.1007/s00330-017-4844.
    PubMed     Text format     Abstract available


  5. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Text format     Abstract available


  6. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Text format     Abstract available


    March 2017
  7. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Text format     Abstract available


  8. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Text format     Abstract available


  9. WEISS J, Taron J, Othman AE, Grimm R, et al
    Feasibility of self-gated isotropic radial late-phase MR imaging of the liver.
    Eur Radiol. 2017;27:985-994.
    PubMed     Text format     Abstract available


  10. LI WD, Yu HY, Qian AM, Rong JJ, et al
    Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Eur Radiol. 2017;27:1227-1237.
    PubMed     Text format     Abstract available


  11. LV P, Liu J, Yan X, Chai Y, et al
    CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
    Eur Radiol. 2017;27:918-926.
    PubMed     Text format     Abstract available


  12. SCHMEEL FC, Simon B, Sabet A, Luetkens JA, et al
    Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Eur Radiol. 2017;27:966-975.
    PubMed     Text format     Abstract available


    February 2017
  13. XU Y, Shen Q, Liu P, Xu Z, et al
    Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Eur Radiol. 2017 Feb 10. doi: 10.1007/s00330-017-4740.
    PubMed     Text format     Abstract available


  14. KIM TH, Kim SH, Lee KB, Han JK, et al
    Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
    Eur Radiol. 2017;27:507-517.
    PubMed     Text format     Abstract available


    January 2017
  15. BANNAS P, Bookwalter CA, Ziemlewicz T, Motosugi U, et al
    Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Eur Radiol. 2017;27:32-40.
    PubMed     Text format     Abstract available


  16. VAN DEN HOVEN AF, Braat MN, Prince JF, van Doormaal PJ, et al
    Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.
    Eur Radiol. 2017;27:61-69.
    PubMed     Text format     Abstract available


  17. JAKOBS TF, Paprottka KJ, Raessler F, Strobl F, et al
    Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.
    Eur Radiol. 2017;27:113-119.
    PubMed     Text format     Abstract available


    December 2016
  18. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  19. KIM M, Kang TW, Jeong WK, Kim YK, et al
    Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  20. SOFUE K, Yoshikawa T, Ohno Y, Negi N, et al
    Improved image quality in abdominal CT in patients who underwent treatment for hepatocellular carcinoma with small metal implants using a raw data-based metal artifact reduction algorithm.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  21. VILGRAIN V, Esvan M, Ronot M, Caumont-Prim A, et al
    A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Eur Radiol. 2016;26:4595-4615.
    PubMed     Text format     Abstract available


    November 2016
  22. PICKHARDT PJ, Malecki K, Hunt OF, Beaumont C, et al
    Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  23. ZECH CJ, Justo N, Lang A, Ba-Ssalamah A, et al
    Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Eur Radiol. 2016;26:4121-4130.
    PubMed     Text format     Abstract available


  24. ROUSSET P, Gregory J, Rousset-Jablonski C, Hugon-Rodin J, et al
    MR diagnosis of diaphragmatic endometriosis.
    Eur Radiol. 2016;26:3968-3977.
    PubMed     Text format     Abstract available


    October 2016
  25. AN C, Rhee H, Han K, Choi JY, et al
    Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  26. COSTA AF, Atri M
    Reply to Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  27. RONOT M, Benzimra J, Bouda D, Vilgrain V, et al
    Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  28. GHOLAMREZANEZHAD A, Mirpour S, Geschwind JF, Rao P, et al
    Evaluation of 70-150-mum doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.
    Eur Radiol. 2016;26:3474-82.
    PubMed     Text format     Abstract available


    September 2016
  29. SUGIHARA F, Murata S, Ueda T, Yasui D, et al
    Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  30. FANG KC, Su CW, Chiou YY, Lee PC, et al
    The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  31. GEEROMS B, Laleman W, Laenen A, Heye S, et al
    Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  32. KIM B, Kim KW, Kim SY, Park SH, et al
    Coronal 2D MR cholangiography overestimates the length of the right hepatic duct in liver transplantation donors.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  33. PARK HJ, Jang KM, Kang TW, Song KD, et al
    Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
    Eur Radiol. 2016;26:3102-11.
    PubMed     Text format     Abstract available


  34. RONOT M, Kerbaol A, Rautou PE, Brancatelli G, et al
    Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.
    Eur Radiol. 2016;26:3094-101.
    PubMed     Text format     Abstract available


  35. FU Y, Peng HJ, Zhang X, Peng WJ, et al
    Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis.
    Eur Radiol. 2016;26:2947-55.
    PubMed     Text format     Abstract available


  36. THAISS WM, Haberland U, Kaufmann S, Spira D, et al
    Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
    Eur Radiol. 2016;26:2929-36.
    PubMed     Text format     Abstract available


    August 2016
  37. LUDWIG JM, Zhang D, Xing M, Kim HS, et al
    Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  38. MIRAGLIA R, Gerasia R, Maruzzelli L, D'Amico M, et al
    Radiation doses to operators performing transjugular intrahepatic portosystemic shunt using a flat-panel detector-based system and ultrasound guidance for portal vein targeting.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  39. HOFFMANN R, Rempp H, Kessler DE, Weiss J, et al
    MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  40. GIRAUDEAU C, Leporq B, Doblas S, Lagadec M, et al
    Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  41. CHOI JW, Kim HC, Lee JH, Yu SJ, et al
    Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  42. HUR S, Chung JW, Zhou CG, Lee JH, et al
    Arteries of the falciform ligament on C-arm CT hepatic arteriography: The hepatic falciform artery and the Sappey's superior artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  43. ZHANG W, Chen HJ, Wang ZJ, Huang W, et al
    Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  44. MOCHE M, Heinig S, Garnov N, Fuchs J, et al
    Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients.
    Eur Radiol. 2016;26:2462-70.
    PubMed     Text format     Abstract available


  45. PIEPER CC, Willinek WA, Thomas D, Ahmadzadehfar H, et al
    Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.
    Eur Radiol. 2016;26:2779-89.
    PubMed     Text format     Abstract available


    July 2016
  46. LEE DH, Lee JM, Yi NJ, Lee KW, et al
    Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  47. COSTA AF, Kajal D, Pereira A, Atri M, et al
    Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  48. MONIER A, Guiu B, Duran R, Aho S, et al
    Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  49. FISCHER MA, Marquez HP, Gordic S, Leidner B, et al
    Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  50. KUMAR G, Goldberg SN, Wang Y, Velez E, et al
    Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  51. GORODETSKI B, Chapiro J, Schernthaner R, Duran R, et al
    Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  52. SANO K, Ichikawa T, Motosugi U, Ichikawa S, et al
    Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  53. GROZINGER G, Mann S, Mehra T, Klumpp B, et al
    Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study.
    Eur Radiol. 2016;26:1826-34.
    PubMed     Text format     Abstract available


  54. CHEN SZ, Yuan J, Deng M, Wei J, et al
    Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.
    Eur Radiol. 2016;26:1792-800.
    PubMed     Text format     Abstract available


    May 2016
  55. TAGUCHI N, Oda S, Utsunomiya D, Funama Y, et al
    Using 80 kVp on a 320-row scanner for hepatic multiphasic CT reduces the contrast dose by 50 % in patients at risk for contrast-induced nephropathy.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  56. WIJNANDS TF, Ronot M, Gevers TJ, Benzimra J, et al
    Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  57. FUJITA N, Asayama Y, Nishie A, Ishigami K, et al
    Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  58. GUIU B, Chevallier P, Denys A, Delhom E, et al
    Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  59. KETELSEN D, Groezinger G, Maurer M, Lauer UM, et al
    Three-dimensional C-arm CT-guided transjugular intrahepatic portosystemic shunt placement: Feasibility, technical success and procedural time.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  60. NERI E, Bali MA, Ba-Ssalamah A, Boraschi P, et al
    ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.
    Eur Radiol. 2016;26:921-31.
    PubMed     Text format     Abstract available


  61. HAIMERL M, Schlabeck M, Verloh N, Zeman F, et al
    Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Eur Radiol. 2016;26:1125-33.
    PubMed     Text format     Abstract available


    March 2016
  62. ZHOU CG, Chung JW, Hur S, Lee M, et al
    Sectional Localization of a Small Hepatocellular Carcinoma in the Right Hepatic Lobe by Computed Tomography: Comparison between the Conventional and Portal Vein Tracing Methods.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  63. VAN BINNEBEEK S, Vanbilloen B, Baete K, Terwinghe C, et al
    Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
    Eur Radiol. 2016;26:900-9.
    PubMed     Text format     Abstract available


  64. VOGL TJ, Schaefer P, Lehnert T, Nour-Eldin NE, et al
    Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
    Eur Radiol. 2016;26:755-63.
    PubMed     Text format     Abstract available


  65. MERKLE EM, Zech CJ, Bartolozzi C, Bashir MR, et al
    Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
    Eur Radiol. 2016;26:674-82.
    PubMed     Text format     Abstract available


    February 2016
  66. FISCHER MA, Brehmer K, Svensson A, Aspelin P, et al
    Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  67. HENNEDIGE TP, Hallinan JT, Leung FP, Teo LL, et al
    Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions.
    Eur Radiol. 2016;26:398-406.
    PubMed     Text format     Abstract available


  68. AMBROSETTI MC, Zamboni GA, Mucelli RP
    Distribution of liver metastases based on the site of primary pancreatic carcinoma.
    Eur Radiol. 2016;26:306-10.
    PubMed     Text format     Abstract available


  69. CHRISTOFIDES D, Leen EL, Averkiou MA
    Improvement of the accuracy of liver lesion DCEUS quantification with the use of automatic respiratory gating.
    Eur Radiol. 2016;26:417-24.
    PubMed     Text format     Abstract available


    January 2016
  70. CHEN Y, Li H, Jiang X, Chen D, et al
    Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  71. LV N, Kong Y, Mu L, Pan T, et al
    Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  72. HUANG M, Lin Q, Wang H, Chen J, et al
    Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  73. FETZER DT, Rees MA, Dasyam AK, Tublin ME, et al
    Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  74. HINRICHS JB, Shin HO, Kaercher D, Hasdemir D, et al
    Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  75. FLECKENSTEIN FN, Schernthaner RE, Duran R, Sohn JH, et al
    3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  76. KANG TW, Rhim H, Lee J, Song KD, et al
    Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  77. HA Y, Lee JB, Shim JH, Kim KM, et al
    Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  78. CHOCKALINGAM A, Duran R, Sohn JH, Schernthaner R, et al
    Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.
    Eur Radiol. 2016;26:103-13.
    PubMed     Text format     Abstract available


  79. WAGNER M, Ronot M, Doblas S, Giraudeau C, et al
    Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Eur Radiol. 2016;26:206-15.
    PubMed     Text format     Abstract available


  80. SENDRA L, Perez D, Miguel A, Herrero MJ, et al
    Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.
    Eur Radiol. 2016;26:95-102.
    PubMed     Text format     Abstract available


    December 2015
  81. KIM YS, Song JS, Lee HK, Han YM, et al
    Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  82. KERAMIDA G, Dizdarevic S, Bush J, Peters AM, et al
    Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Eur Radiol. 2015;25:2701-8.
    PubMed     Text format     Abstract available


    August 2015
  83. YU MH, Lee JM, Hur BY, Kim TY, et al
    Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Eur Radiol. 2015;25:2428-36.
    PubMed     Text format     Abstract available


  84. WAGNER M, Mariani P, Bidard FC, Rodrigues MJ, et al
    Diffusion-weighted MRI for uveal melanoma liver metastasis detection.
    Eur Radiol. 2015;25:2263-73.
    PubMed     Text format     Abstract available


    July 2015
  85. KIM SH, Kim SH, Kim MA, Shin CI, et al
    CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
    Eur Radiol. 2015;25:1946-57.
    PubMed     Text format     Abstract available


  86. CHAPIRO J, Duran R, Lin M, Schernthaner R, et al
    Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
    Eur Radiol. 2015;25:1993-2003.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: